Text Size

Evaluation of Preoperative Investigations in Patients With Liver Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by Odense University Hospital.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Odense University Hospital
ClinicalTrials.gov Identifier:
NCT00408122
First received: December 5, 2006
Last updated: February 4, 2009
Last verified: February 2009
History of Changes
  Purpose

The aim of the study is to evaluate the diagnostic procedures emission tomography in combination with a CT scan (PET/CT) and endoscopic ultrasonography (EUS) in the preoperative evaluation of resectability of patients with primary or secondary liver cancers.


Condition Intervention
Primary Liver Cancer
Liver Metastasis
 Procedure: PET/CT scan and EUS

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of Positron Emission Tomography/ CT Scan, Endoscopic Ultrasono¬Graphy, and Laparoscopic Ultrasonography in the Preoperative Assess¬Ment of Resectability in Patients With Primary and Secondary Liver Cancer

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Odense University Hospital:

Enrollment: 77
Study Start Date: January 2007
Estimated Study Completion Date: December 2009
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • all patients who are referred to The Department of Surgery, Odense University Hospital, for surgical treatment of suspected or biopsy proven primary or secondary liver cancer.

Exclusion Criteria:

  • age less than 18 years
  • patients who are not fit for liver surgery because of co-morbidity

  • patients for whom the extra investigations in the study are considered to give an increased risk because of co-morbidity such as

    • Patients with s-creatinin > 150 micromol/l
    • Patients who take peroral antidiabetic drugs or have a poorly regulated diabetes mellitus
  • patients who do not understand the patient information
  • patients who do not want to participate
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00408122

Locations
Denmark
Dept of Surgery, Odense university Hospital
Odense, Denmark, 5000
Sponsors and Collaborators
Odense University Hospital
Investigators
Principal Investigator: Henning O Nielsen, MD, DMsc dept. of Surgery, Odense University Hospital
  More Information

No publications provided

Responsible Party: Dr Henning Overgaatd Nielsen, Odense University Hospital
ClinicalTrials.gov Identifier: NCT00408122     History of Changes
Other Study ID Numbers: VF-20060109
Study First Received: December 5, 2006
Last Updated: February 4, 2009
Health Authority: Denmark: Ethics Committee

Additional relevant MeSH terms:
Liver Neoplasms
Neoplasm Metastasis
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
 Digestive System Diseases
Liver Diseases
Neoplastic Processes
Pathologic Processes

ClinicalTrials.gov processed this record on May 19, 2013